Stock BMY BRISTOL-MYERS SQUIBB COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-28 pm EDT 		Pre-market 07:59:42 pm
40.49 USD -1.82% Intraday chart for Bristol-Myers Squibb Company 40.52 +0.07%
May. 28 Prothena to Receive $80 Million From Bristol-Myers Squibb For PRX019 Global License MT
May. 27 Bristol Myers: will present data on schizophrenia CF

Evolution of the average Target Price on Bristol-Myers Squibb Company

Price target over the last 5 years

History of analyst recommendation changes

cba78dc.xgBBIOd6xyGZho0-Ys7HB8vXOygXBsrWBJ5-DeJDlTA.n002a59PrlHx__RLBfakav-BSF5zX6GnNfQXZ6sB1lqpSXYWgRHxZfK-zA~10d35372b9424f1f5deb6c09db618c10

Analyst Recommendations on Bristol-Myers Squibb Company

HSBC Adjusts Price Target on Bristol-Myers Squibb to $45 From $50 MT
ANALYST RECOMMENDATIONS : Tesla, Snap, Alphabet, Microsoft, Anglo American... Our Logo
Goldman Sachs Cuts Bristol-Myers Squibb's Price Target to $56 From $60 MT
Deutsche Bank Adjusts Price Target on Bristol-Myers Squibb to $53 From $55, Keeps Hold Rating MT
Leerink Partners Cuts Price Target on Bristol-Myers Squibb to $47 From $51 MT
UBS Cuts Bristol-Myers Squibb Price Target to $47 From $52, Maintains Neutral Rating MT
Barclays Adjusts Price Target on Bristol-Myers Squibb to $43 From $51 MT
JPMorgan Adjusts Bristol-Myers Squibb's Price Target to $60 From $65 MT
Morgan Stanley Adjusts Price Target on Bristol-Myers Squibb Company to $37 From $40 MT
Truist Cuts Price Target on Bristol-Myers Squibb to $64 From $68, Keeps Buy Rating MT
BMO Capital Adjusts Price Target on Bristol-Myers Squibb Company to $48 From $55 MT
Jefferies Adjusts Bristol-Myers Squibb Price Target to $54 From $56, Keeps Hold Rating MT
Cantor Fitzgerald Adjusts Price Target on Bristol-Myers Squibb to $45 From $52, Maintains Neutral Rating MT
Cantor Fitzgerald Adjusts Bristol-Myers Squibb's Price Target to $52 From $55, Maintains Neutral Rating MT
Wells Fargo Adjusts Bristol-Myers Squibb's Price Target to $52 From $51, Keeps Equalweight Rating MT
Wolfe Research Adjusts Price Target on Bristol-Myers Squibb Company to $55 From $57, Outperform Rating Kept MT
Wolfe Research Adjusts Price Target on Bristol-Myers Squibb to $55 From $57, Maintains Outperform Rating MT
Jefferies Cuts Bristol-Myers Squibb's Price Target to $56 From $58 MT
Morgan Stanley Trims Price Target on Bristol-Myers Squibb to $40 From $41, Keeps Underweight Rating MT
Societe Generale Downgrades Bristol-Myers Squibb to Hold From Buy, Cuts Price Target to $51 From $85 MT
Wells Fargo Adjusts Price Target on Bristol-Myers Squibb to $51 From $58, Maintains Equalweight Rating MT
Redburn Downgrades Bristol-Myers Squibb to Neutral From Buy, Adjusts Price Target to $54 From $77 MT
That's good enough for investors Our Logo
ANALYST RECOMMENDATIONS : Chevron, McDonald's, Palantir, Sainsbury, Tesla... Our Logo
Morgan Stanley Trims Price Target on Bristol-Myers Squibb to $41 From $42, Incorporates Mirati Transaction Into Model; Underweight Kept MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.49 USD
Average target price
53.19 USD
Spread / Average Target
+31.38%
High Price Target
75 USD
Spread / Highest target
+85.23%
Low Price Target
37 USD
Spread / Lowest Target
-8.62%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Bristol-Myers Squibb Company

HSBC
Goldman Sachs
Deutsche Bank Securities
Leerink Partners
UBS
Barclays
JPMorgan Chase
Morgan Stanley
Truist Securities
BMO Capital
Jefferies & Co.
Cantor Fitzgerald
Wells Fargo Securities
Wolfe Research
Societe Generale
Redburn
BofA Securities
Daiwa Securities
Berenberg Bank
William Blair & Co.
TD Cowen
Credit Suisse
Atlantic Equities
Guggenheim
Raymond James
Citigroup
Argus

Ratings for Bristol-Myers Squibb Company

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BMY Stock
  4. Consensus Bristol-Myers Squibb Company